Back
United Therapeutics Stock Predictions
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
58
UTHR
United Therapeutics
Last Price:
$314.18
Seasonality Move:
3.89%
7 Day Trial
ALL ACCESS PASS
$
7
Economy going through a "period of transition" - Your portfolio doesn't have to
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.United Therapeutics Stock Forecast
-
Over the next 52 weeks, United Therapeutics has on average historically risen by 18.5% based on the past 25 years of stock performance.
-
United Therapeutics has risen higher in 16 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 64%
-
Is United Therapeutics Stock Undervalued?The current United Therapeutics [UTHR] share price is $322.94. The Score for UTHR is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
UTHR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will United Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, United Therapeutics has on average historically risen by 18.5% based on the past 25 years of stock performance.
United Therapeutics Stock Rating
Buy
58
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics overpriced?
-
United Therapeutics has risen higher in 16 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 64%
United Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
unither.com
52-Week Data
52-Week High:
417.82
52-Week Low:
221.53
Prediction Charts
Market Cap:
14.5B
Price in USD:
322.94
Volume:
400.6K
Beta:
0.53
Technical Analysis
SMA50:
349.30
SMA100:
359.98
SMA200:
343.81
52-Wk Change:
36.97%
Stock Predictions
-
Is United Therapeutics stock public?Yes, United Therapeutics is a publicly traded company.
-
What is the United Therapeutics stock quote today?The United Therapeutics stock price is 322.94 USD today.
-
How to buy United Therapeutics stock online?You can buy United Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-25 | 362.42 | 357.49 | 364.98 | 351.08 |
| Feb-26 | 343.53 | 318.89 | 344.81 | 307.38 |
| Feb-27 | 318.80 | 323.57 | 326.74 | 315.07 |
| Feb-28 | 324.06 | 320.05 | 324.06 | 313.66 |
| Mar-3 | 316.46 | 309.48 | 320.76 | 307.92 |
| Mar-4 | 308.09 | 308.46 | 315.53 | 305.33 |
| Mar-5 | 307.40 | 310.89 | 312.86 | 306.49 |
| Mar-6 | 309.06 | 307.35 | 311.87 | 305.00 |
| Mar-7 | 307.15 | 315.91 | 320.81 | 306.11 |
| Mar-11 | 314.74 | 304.42 | 318.06 | 303.62 |
| Mar-12 | 304.22 | 307.09 | 307.73 | 301.25 |
| Mar-13 | 306.88 | 305.39 | 307.98 | 299.47 |
| Mar-14 | 305.06 | 307.24 | 310.17 | 305.06 |
| Mar-17 | 307.86 | 322.94 | 324.22 | 304.55 |
United Therapeutics Earnings
United Therapeutics Earnings Report: Per Share United Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
United Therapeutics Forecast Revenue Growth
United Therapeutics Stock Analysis: Historical quarterly revenues per share for United Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.78 per share, a decrease next quarter of $0.81 per share, an increase this year of $2.78 per share, and an increase next year of $0.04 per share.
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.